Gait and Balance Impairments in Dementia

A Phase 2 study evaluating the effect of intepirdine on gait and balance in subjects with Alzheimer’s disease, dementia with Lewy bodies or Parkinson’s disease dementia.

In this study, Axovant intends to further investigate the observation of a reduced rate of falls seen in subjects treated with intepirdine in a prior 684-patient study of intepirdine on a background of stable donepezil therapy.

Compound:
Intepirdine

Therapeutic Area(s):

  • Alzheimer's disease
  • Dementia with Lewy bodies (DLB)
  • Parkinson's disease dementia

For More Information:
ClinicalTrials.gov